Written Question · S1W-09402 · Session 1
Whether it will make Copaxone available to multiple sclerosis patients through the NHS.
The question
To ask the Scottish Executive whether it will make Copaxone available to multiple sclerosis patients through the NHS.
The answer
Copaxone (Glatiramer) has been recently licensed for use in the treatment of certain patients with relapsing-remitting multiple sclerosis. It is a matter for each health board to determine its prescribing policy on drugs, taking into account advice from local Drug and Therapeutics Committees.The Health Technology Board for Scotland is at present carrying out an assessment of Beta Interferon and Copaxone in the treatment of multiple sclerosis.
In the Official Report
No contribution in the Official Report cites S1W-09402 by reference.